PMID- 17608263
OWN - NLM
STAT- MEDLINE
DCOM- 20070918
LR  - 20220331
IS  - 0960-8923 (Print)
IS  - 0960-8923 (Linking)
VI  - 17
IP  - 4
DP  - 2007 Apr
TI  - Intragastric balloon and binge eating.
PG  - 504-9
AB  - BACKGROUND: In recent years, particular attention has been paid to the effect 
      that eating disturbances and especially binge eating can have on the outcome of 
      surgical treatments for obesity. Endoscopic positioning of the Bioenterics 
      intragastric balloon (BIB) is mainly used in the work-up for surgical treatment 
      of morbid obesity. Available data show that the BIB is a valid tool for reducing 
      weight and co-morbidity, even if only a temporary treatment in morbidly obese 
      patients. We evaluated the results of treatment with the BIB with the patient's 
      tendency to indulge in binge eating. METHODS: Between April 2003 and March 2006, 
      89 patients with morbid obesity (BMI 39-55) were enrolled in the study. Before 
      introducing the BIB and within 3 months after removal, patients underwent a 
      psychiatric evaluation and the following psychodiagnostic tests: SCID (Structured 
      Clinical Interview for DSM IV), ED-SCID (Eating Disorder Module, Structured 
      Clinical Interview) and BSQ (Binge Scale Questionnaire). All those positive for 
      the BED criteria according to the DSM IV, and who had at least one binge eating 
      episode per week, were considered Binge Eaters (BE). RESULTS: Of the 89 patients 
      enrolled, 75 were eligible for evaluations (M:F = 12:63), and 27 were positive 
      for binge eating (BE). There were no significant differences in age and 
      preoperative BMI between the BE group and the 48 patients without BE (NBE group). 
      The complication and failure rates with the BIB treatment were significantly 
      higher in the BE group (P<0.01). After treatment with the BIB, both groups showed 
      a significant reduction in BMI (P<0.01), but the NBE-group showed a significantly 
      higher weight (BMI 5.7 +/- 2.5 kg/m2) than the BE-group (BMI 3.3 +/- 2.2 kg/m2) 
      (P=0.03). CONCLUSION: The results of treatment with the intragastric balloon 
      appear to be affected by binge eating pattern in morbidly obese patients, even if 
      the presence of this behavior does not prevent a successful reduction in the BMI. 
      Binge eating does not seem to be a contraindication for the adjuvant use of the 
      BIB before a bariatric operation. A limitation of our study is the short period 
      of observation, related to the period of the BIB in the gastric lumen (not more 
      than 6 months). Further studies may show whether the association of psychiatric 
      treatment with the BIB in patients affected by binge eating may enhance the 
      results of the treatment.
FAU - Puglisi, Francesco
AU  - Puglisi F
AD  - D.E.T.O., Sezione di Chirurgia Generale e Trapianto di Fegato, Universita di 
      Bari, Italy. g.bros@tiscali.it
FAU - Antonucci, Nicola
AU  - Antonucci N
FAU - Capuano, Palma
AU  - Capuano P
FAU - Zavoianni, Leonardo
AU  - Zavoianni L
FAU - Lobascio, Pierluigi
AU  - Lobascio P
FAU - Martines, Gennaro
AU  - Martines G
FAU - Lograno, Giuseppe
AU  - Lograno G
FAU - Memeo, Vincenzo
AU  - Memeo V
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Obes Surg
JT  - Obesity surgery
JID - 9106714
SB  - IM
MH  - Adult
MH  - Body Mass Index
MH  - Bulimia/complications/*epidemiology
MH  - Device Removal
MH  - Female
MH  - Follow-Up Studies
MH  - *Gastric Balloon
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Obesity, Morbid/*psychology/*therapy
MH  - Prevalence
MH  - Retrospective Studies
MH  - Treatment Outcome
MH  - Weight Loss
EDAT- 2007/07/05 09:00
MHDA- 2007/09/19 09:00
CRDT- 2007/07/05 09:00
PHST- 2007/07/05 09:00 [pubmed]
PHST- 2007/09/19 09:00 [medline]
PHST- 2007/07/05 09:00 [entrez]
AID - 10.1007/s11695-007-9088-0 [doi]
PST - ppublish
SO  - Obes Surg. 2007 Apr;17(4):504-9. doi: 10.1007/s11695-007-9088-0.